New campaign will highlight Kate Walsh’s journey with dry eye and how finding the right solution of Systane helped her reconnect with what matters Partnership supports the launch of Systane Complete ...

Alcon has not received any reports of adverse events related to this recall. However, the company is acting cautiously to ensure consumer safety. On Dec. 21, Alcon Laboratories issued a voluntary ...

Systane Lubricant Eye Drops in a green and pink carton design, with “Systane” and “ULTRA PF” brand names on the front of the carton, and the “25 vials” package size marked Lot 10101 were recalled for ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of SYSTANE ® PRO Preservative-Free (PF) as ...

May 28 (Reuters) - (This May 28 story has been corrected to say 'eye drop,' not 'liquid medication,' in paragraph 3 and to remove the picture) Eye-care drugmaker Alcon (ALCC.S), opens new tab said on ...

Alcon’s $770 million takeover of Aerie Pharmaceuticals has delivered an early win. The lead candidate in the acquired pipeline met the primary endpoint in a pair of phase 3 dry eye trials, positioning ...

Between long days staring at your computer screen at the office and scrolling through social media, reports indicate that digital eye strain affects 6 out of 10 Americans and increases the likelihood ...

Please provide your email address to receive an email when new articles are posted on . The TRPM8 receptor agonist increases natural tear production as early as day 1. Alcon also launched a campaign ...

SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- On August 13th 2024, Ocumension Therapeutics ("OcuMension") announced an agreement with Alcon Inc. ("Alcon", and collectively with OcuMension, the "Parties") ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Alcon Plc’s (NYSE:ALC) Tryptyr (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for signs and symptoms of Dry Eye ...

(RTTNews) - Ocumension Therapeutics, Monday announced an agreement to acquire commercialization rights of a Chinese portfolio of dry eye treatments and procedural drops of Alcon Inc. (ALC), in ...